{
  "ticker": "VRTX",
  "last_updated": "2026-02-25T09:02:42.979598",
  "retention_years": 3,
  "count": 23,
  "transactions": [
    {
      "id": 1494,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-02-19",
      "transaction_shares": "23479",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "92521"
    },
    {
      "id": 1477,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-02-17",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "71182"
    },
    {
      "id": 1480,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP, CO & FO",
      "transaction_date": "2026-02-17",
      "transaction_shares": "7365",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51080"
    },
    {
      "id": 1481,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2026-02-17",
      "transaction_shares": "16326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149813"
    },
    {
      "id": 1482,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "McKechnie Duncan",
      "reporting_owner_cik": "0002062139",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2026-02-17",
      "transaction_shares": "4962",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24490"
    },
    {
      "id": 1483,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2026-02-17",
      "transaction_shares": "5789",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51921"
    },
    {
      "id": 1486,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2026-02-17",
      "transaction_shares": "1809",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10543"
    },
    {
      "id": 1488,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2026-02-17",
      "transaction_shares": "4962",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25105"
    },
    {
      "id": 1490,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2026-02-17",
      "transaction_shares": "5375",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "43428"
    },
    {
      "id": 1491,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bunnage Mark E.",
      "reporting_owner_cik": "0002100735",
      "reporting_owner_position": "EVP, Chief Scientific Officer",
      "transaction_date": "2026-02-17",
      "transaction_shares": "2584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13215"
    },
    {
      "id": 1495,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2026-02-17",
      "transaction_shares": "8269",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "41308"
    },
    {
      "id": 1496,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2026-02-17",
      "transaction_shares": "4135",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "20973"
    },
    {
      "id": 1476,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP, CO & FO",
      "transaction_date": "2026-02-13",
      "transaction_shares": "4565",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "43715"
    },
    {
      "id": 1478,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bunnage Mark E.",
      "reporting_owner_cik": "0002100735",
      "reporting_owner_position": "EVP, Chief Scientific Officer",
      "transaction_date": "2026-02-13",
      "transaction_shares": "2283",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "10631"
    },
    {
      "id": 1479,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2026-02-13",
      "transaction_shares": "3804",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "47632"
    },
    {
      "id": 1484,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2026-02-13",
      "transaction_shares": "1393",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "8734"
    },
    {
      "id": 1485,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2026-02-13",
      "transaction_shares": "266",
      "transaction_price": "500",
      "transaction_type": "S",
      "shares_after_transaction": "4299"
    },
    {
      "id": 1487,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2026-02-13",
      "transaction_shares": "3804",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "38053"
    },
    {
      "id": 1489,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2026-02-13",
      "transaction_shares": "2993",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "17826"
    },
    {
      "id": 1492,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2026-02-13",
      "transaction_shares": "1903",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "20143"
    },
    {
      "id": 1493,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-02-13",
      "transaction_shares": "3548",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "65393"
    },
    {
      "id": 1497,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "McKechnie Duncan",
      "reporting_owner_cik": "0002062139",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2026-02-13",
      "transaction_shares": "2283",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "19528"
    },
    {
      "id": 1498,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2026-02-13",
      "transaction_shares": "13041",
      "transaction_price": "487.76",
      "transaction_type": "F",
      "shares_after_transaction": "133487"
    }
  ]
}